Locations:

Tag: fda

May 19, 2021/Otolaryngology & Dentistry/Technology & Treatments

FDA Approves New Surgical Approach for Neurostimulation Device to Treat OSA

A reduction in the number of incisions for implantation simplifies the procedure and improves patient experience

21-NEU-2050870_woman-in-wheelchair_650x450

February 15, 2021/Neurosciences/Multiple Sclerosis

How Do Patients With Multiple Sclerosis Perceive the U.S. Drug Approval Process?

Survey suggests need for education about FDA’s mission, trustworthiness

April 23, 2018/Neurosciences/Insight & Perspectives

Generics and Biosimilars in Multiple Sclerosis: Navigating a New Therapy Landscape

What neurologists need to know about this emerging development

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy